share_log

HOOKIPA Pharma | DEFA14A: Others

HOOKIPA Pharma | DEFA14A: Others

HOOKIPA Pharma | DEFA14A:其他
美股SEC公告 ·  04/26 16:45

Moomoo AI 已提取核心訊息

HOOKIPA Pharma Inc. has filed a DEFA14A form with the United States Securities and Exchange Commission (SEC), indicating the submission of additional proxy soliciting materials. The filing, which is part of the regulatory requirements under Section 14(a) of the Securities Exchange Act of 1934, does not require a filing fee. This submission by HOOKIPA Pharma is a definitive additional material, suggesting that it is likely a follow-up to a previously filed proxy statement. The materials are intended for use in connection with a shareholder meeting or vote, although the specific resolutions or proposals are not detailed in the announcement.
HOOKIPA Pharma Inc. has filed a DEFA14A form with the United States Securities and Exchange Commission (SEC), indicating the submission of additional proxy soliciting materials. The filing, which is part of the regulatory requirements under Section 14(a) of the Securities Exchange Act of 1934, does not require a filing fee. This submission by HOOKIPA Pharma is a definitive additional material, suggesting that it is likely a follow-up to a previously filed proxy statement. The materials are intended for use in connection with a shareholder meeting or vote, although the specific resolutions or proposals are not detailed in the announcement.
HOOKIPA Pharma Inc. 已向美國證券交易委員會(SEC)提交了一份 DEFA14A 表格,表示將提交額外的代理招標材料。該文件是1934年《證券交易法》第14(a)條監管要求的一部分,不需要繳納申請費。HOOKIPA Pharma提交的這份文件是明確的補充材料,表明這可能是先前提交的委託書的後續文件。儘管公告中未詳細說明具體的決議或提案,但這些材料旨在用於股東大會或投票。
HOOKIPA Pharma Inc. 已向美國證券交易委員會(SEC)提交了一份 DEFA14A 表格,表示將提交額外的代理招標材料。該文件是1934年《證券交易法》第14(a)條監管要求的一部分,不需要繳納申請費。HOOKIPA Pharma提交的這份文件是明確的補充材料,表明這可能是先前提交的委託書的後續文件。儘管公告中未詳細說明具體的決議或提案,但這些材料旨在用於股東大會或投票。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息